9-Me-BC
nine-MEH-BEE-see
Category
Compound type
Phase / Status
Research chemical
Standard Dose
As directed
Half-life
Plasma elimination
Route(s)
Oral, Injectable or Topical
Research Stage
Research phase not specified; exercise appropriate caution.
Overview
9-Me-BC is often described as a "mental clarity" compound, with users reporting improvements in focus, mood, and motivation. The key caveat is that most information comes from limited research and anecdotal reports, so it's hard to know what to expect - or how consistent the effects truly are. If you're looking at 9-Me-BC, treat it as experimental, avoid combining it with other psychoactive substances, and stop if you feel unwell.
Plain-language summary
9-Me-BC is often described as a "mental clarity" compound, with users reporting improvements in focus, mood, and motivation. The key caveat is that most information comes from limited research and anecdotal reports, so it's hard to know what to expect - or how consistent the effects truly are. If you're looking at 9-Me-BC, treat it as experimental, avoid combining it with other psychoactive substances, and stop if you feel unwell.
Administration Routes
- Oral
- Injectable
- Topical
Also known as
Mechanisms
Dopaminergic nootropic
Detailed mechanism
9-Me-BC inhibits monoamine oxidase (MAO-A and MAO-B), raising synaptic concentrations of dopamine, serotonin, and norepinephrine in regions involved in motivation and cognition. It also stimulates astrocyte expression of neurotrophic factors including BDNF and GDNF, which drive hippocampal dendritic and synaptic proliferation in preclinical models. These combined dopaminergic and neurotrophic actions are proposed to underlie the cognitive and mood effects reported by researchers, though human pharmacokinetics and long-term safety remain poorly characterized.
Safety
Side effects
- Limited research
- Unknown long-term effects
Reported benefits
- Cognitive enhancement
- Mood improvement
Safety profile
Consult medical professional before use
Clinical trials
See research status
Structure
Verified structure
9-Me-BC
Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.
- Chemical Formula
- C12H10N2
- Molecular Weight
- 182.22 g/mol
- CAS Number
- 2521-07-5
- InChIKey
- MABOIYXDALNSES-UHFFFAOYSA-N
Stack Context
No stack data available.
References
- 1View source
9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation (J Neural Transm)
2012
- 2View source
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes (Neuropharmacology)
2020
- 3View source
Inhibition of human monoamine oxidase A and B by the beta-carboline alkaloids and their homologs (J Agric Food Chem)
2006
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.